Insight Molecular Diagnostics Inc. Common Stock (IMDX) Stock Price, Quote & AI Analysis
Live IMDX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Insight Molecular Diagnostics Inc. Common Stock.
TradeVae provides AI-driven analysis and real-time market intelligence for Insight Molecular Diagnostics Inc. Common Stock (IMDX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Insight Molecular Diagnostics Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Insight Molecular Diagnostics Inc. Common Stock Overview
Company information
Company Overview
Insight Molecular Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Nashville, TN.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Insight Molecular Diagnostics Inc. Common Stock Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...